This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Today, the U.S. Food and Drug Administration announced that Commissioner Margaret A. Hamburg, M.D. will travel Feb. 10-18 to India to further strengthen cooperation between the FDA and its Indian regulatory counterparts.
During the trip, which will include visits to Delhi, Cochin, and Mumbai, Commissioner Hamburg will meet with Indian policy and government leaders involved in the regulation of medical and food products exported to the United States. Indian regulators are important strategic partners to the FDA and regular engagement is essential. Currently, India is the second largest provider of finished drug products and the eighth largest exporter of food products to the United States.
“The FDA’s ongoing engagement with our regulatory counterparts in India is critical to our ability to effectively promote the health and safety of American and Indian consumers,” said Commissioner Hamburg. “I look forward to enhancing our existing relationship and identifying additional opportunities for collaboration.”
The cooperation of United States and Indian food and drug officials is wide ranging, from sharing information on the conduct of clinical trials to jointly addressing product safety issues that may have an impact on both American and Indian consumers. Commissioner Hamburg will also meet with industry leaders in India to discuss the importance of maintaining high-quality standards in producing goods to ensure consumers have access to safe products.
This is Commissioner Hamburg’s first official trip to India.
For more information:
